Role of pre-existing incomplete intestinal metaplasia in gastric adenocarcinoma: A retrospective case series analysis

World J Clin Cases. 2023 Apr 26;11(12):2708-2715. doi: 10.12998/wjcc.v11.i12.2708.

Abstract

Background: Risk stratification for patients with gastric precancerous lesions for endoscopic surveillance remains controversial.

Aim: To analysis of patients having developed gastric adenocarcinoma during the period of follow-up.

Methods: We conducted a retrospective study on patients having undergone upper endoscopy prior to the development of gastric adenocarcinoma. The presence and stage of precancerous lesions as well as subtype of intestinal metaplasia at the baseline endoscopy got evaluated. Literature mini-review was performed.

Results: Out of 1681 subjects in the Biobank, gastric adenocarcinoma was detected in five cases in whom previous endoscopy data with biopsies either from the corpus or antral part were available. All of the patients had incomplete intestinal metaplasia during the baseline endoscopy; all three subjects in whom intestinal metaplasia subtyping was performed according to Filipe et al, had Type III intestinal metaplasia. Two of the five cases had low Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastritis Intestinal Metaplasia Assessment (OLGIM) stages (I-II) at the baseline.

Conclusion: The presence of incomplete intestinal metaplasia, in particular, that of Type III is a better predictor for gastric adenocarcinoma development than OLGA/OLGIM staging system. Subtyping of intestinal metaplasia have an important role in the risk stratification for surveillance decisions.

Keywords: Gastric adenocarcinoma; Minireview; OLGA/OLGIM staging; Precancerous lesions; Retrospective study; Subtypes of intestinal metaplasia.